• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-200c 的下调与口腔鳞状细胞癌的不良预后相关。

Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.

机构信息

State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, 610000, China.

Department of Stomatology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116000, China.

出版信息

Int J Clin Oncol. 2020 Jun;25(6):1072-1078. doi: 10.1007/s10147-020-01649-2. Epub 2020 Mar 11.

DOI:10.1007/s10147-020-01649-2
PMID:32162011
Abstract

BACKGROUND

MicroRNAs (miRNAs) are considered as promising cancer biomarkers. The aim of the present study is to investigate the prognostic significance of miR-200c in patients with oral squamous cell carcinoma (OSCC).

MATERIALS AND METHODS

Quantitative real-time PCR (qRT-PCR) was used to determine the expression levels of miR-200c in 204 pairs of OSCC and adjacent noncancerous. Correlations between miR-200c expression levels and clinicopathological characteristics were investigated. Survival analysis was performed using the Kaplan-Meier method and log-rank test. Multivariate analysis of the prognostic factors was performed with a Cox proportional hazards regression model.

RESULTS

The expression of miR-200c was significantly down-regulated in OSCC tissues compared with adjacent non-tumor tissues (p < 0.0001). Low expression of miR-200c in tumor tissues was significantly correlated with the positive N classification (p = 0.013), advanced TNM stage (p = 0.007) and poor differentiation grade (p = 0.026). Lower miR-200c expression in patients was significantly associated with poor recurrence-free survival (RFS, p = 0.0003) and overall survival (OS, p = 0.0026). Multivariate analysis confirmed that low miR-200c expression was an independent predictor for poor RFS (hazard ratio (HR) 1.705, 95% CI 1.136-2.56, p = 0.01) and OS (HR 1.669, 95% CI 1.03-2.703, p = 0.037) in patients with OSCC.

CONCLUSION

Our results suggest that the miR-200c might be a potential prognostic biomarker for OSCC.

摘要

背景

微小 RNA(miRNAs)被认为是有前途的癌症生物标志物。本研究旨在探讨 miR-200c 在口腔鳞状细胞癌(OSCC)患者中的预后意义。

材料与方法

采用实时定量 PCR(qRT-PCR)检测 204 对 OSCC 及相邻非癌组织中 miR-200c 的表达水平。分析 miR-200c 表达水平与临床病理特征的相关性。采用 Kaplan-Meier 法和对数秩检验进行生存分析。采用 Cox 比例风险回归模型进行预后因素的多因素分析。

结果

miR-200c 在 OSCC 组织中的表达明显低于相邻非肿瘤组织(p<0.0001)。肿瘤组织中 miR-200c 的低表达与 N 分类阳性(p=0.013)、TNM 分期较晚(p=0.007)和分化程度差(p=0.026)显著相关。患者 miR-200c 表达水平较低与无复发生存率(RFS,p=0.0003)和总生存率(OS,p=0.0026)显著相关。多因素分析证实,miR-200c 低表达是 OSCC 患者 RFS(风险比(HR)1.705,95%CI 1.136-2.56,p=0.01)和 OS(HR 1.669,95%CI 1.03-2.703,p=0.037)的独立预测因子。

结论

我们的研究结果表明,miR-200c 可能是 OSCC 的一个潜在预后生物标志物。

相似文献

1
Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.miR-200c 的下调与口腔鳞状细胞癌的不良预后相关。
Int J Clin Oncol. 2020 Jun;25(6):1072-1078. doi: 10.1007/s10147-020-01649-2. Epub 2020 Mar 11.
2
Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.miR-448 在口腔鳞状细胞癌中的表达与预后相关。
BMC Cancer. 2020 Aug 12;20(1):756. doi: 10.1186/s12885-020-07243-z.
3
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.miR-92b 作为晚期口腔鳞状细胞癌患者 TPF 诱导化疗反应预测和预后评估的标志物。
Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):24-31.
4
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.血清微小RNA-483-5p:口腔鳞状细胞癌患者一种新型的诊断和预后生物标志物。
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
5
Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma.微小RNA-1246在人口腔鳞状细胞癌中的表达及临床意义
Med Sci Monit. 2015 Mar 16;21:776-81. doi: 10.12659/MSM.892508.
6
MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.微小RNA-200c在肝细胞癌中的表达降低,且与预后不良相关。
Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):715-721. doi: 10.1016/j.clinre.2019.03.005. Epub 2019 Apr 6.
7
MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.miR-200c 通过靶向 Akt 通路及其下游的 Glut1 抑制口腔鳞状细胞癌细胞的增殖。
Arch Oral Biol. 2018 Dec;96:52-57. doi: 10.1016/j.archoralbio.2018.06.003. Epub 2018 Jun 6.
8
MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.微小RNA-375通过靶向胰岛素样生长因子1受体抑制口腔鳞状细胞癌的生长并增强其放射敏感性。
Cell Physiol Biochem. 2017;42(5):2105-2117. doi: 10.1159/000479913. Epub 2017 Aug 15.
9
Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.微小RNA-143在人口腔鳞状细胞癌中的表达降低及其肿瘤抑制功能
Genet Mol Res. 2015 Jun 26;14(2):6943-52. doi: 10.4238/2015.June.26.2.
10
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.全基因组唾液 microRNA 研究鉴定 miR-423-5p 作为口腔鳞状细胞癌有前途的诊断和预后生物标志物。
Theranostics. 2021 Jan 1;11(6):2987-2999. doi: 10.7150/thno.45157. eCollection 2021.

引用本文的文献

1
Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review.口腔鳞状细胞癌发生的分子机制:文献综述
Biomolecules. 2025 Apr 25;15(5):621. doi: 10.3390/biom15050621.
2
MicroRNA-200c in Cancer Generation, Invasion, and Metastasis.微小RNA-200c在癌症发生、侵袭和转移中的作用
Int J Mol Sci. 2025 Jan 16;26(2):710. doi: 10.3390/ijms26020710.
3
Progress in Precision Medicine for Head and Neck Cancer.头颈癌精准医学的进展

本文引用的文献

1
Oral potentially malignant disorders: A comprehensive review on clinical aspects and management.口腔潜在恶性疾病:临床方面和管理的综合综述。
Oral Oncol. 2020 Mar;102:104550. doi: 10.1016/j.oraloncology.2019.104550. Epub 2020 Jan 22.
2
MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.口腔鳞状细胞癌中的 microRNA 表达模式:hsa-mir-99b-3p 和 hsa-mir-100-5p 作为口腔癌的新型预后标志物。
Head Neck. 2019 Oct;41(10):3499-3515. doi: 10.1002/hed.25866. Epub 2019 Jul 29.
3
MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
Cancers (Basel). 2024 Nov 4;16(21):3716. doi: 10.3390/cancers16213716.
4
Sample-to-answer salivary miRNA testing: New frontiers in point-of-care diagnostic technologies.样本到答案的唾液 miRNA 检测:即时诊断技术的新前沿。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 May-Jun;16(3):e1969. doi: 10.1002/wnan.1969.
5
MicroRNA-200c Release from Gelatin-Coated 3D-Printed PCL Scaffolds Enhances Bone Regeneration.明胶涂层 3D 打印聚己内酯支架释放 microRNA-200c 增强骨再生。
ACS Biomater Sci Eng. 2024 Apr 8;10(4):2337-2350. doi: 10.1021/acsbiomaterials.3c01105. Epub 2024 Mar 26.
6
CaCO Nanoparticles Delivering MicroRNA-200c Suppress Oral Squamous Cell Carcinoma.碳酸钙纳米颗粒递送 microRNA-200c 抑制口腔鳞状细胞癌。
J Dent Res. 2024 Feb;103(2):147-155. doi: 10.1177/00220345231216110. Epub 2023 Dec 27.
7
The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review.头颈部鳞状细胞癌中潜在的微小RNA预后标志物:一项系统评价
Noncoding RNA. 2023 Sep 14;9(5):54. doi: 10.3390/ncrna9050054.
8
Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.头颈部癌症化疗耐药及 miRNA 表达的临床研究:一项符合 PRISMA 规范的全面系统评价和综合荟萃分析。
Genes (Basel). 2022 Dec 10;13(12):2325. doi: 10.3390/genes13122325.
9
Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol.头颈部癌症中化疗耐药性与敏感性及 miRNA 表达的临床治疗相关性:系统评价和荟萃分析方案。
Genes (Basel). 2021 Dec 20;12(12):2029. doi: 10.3390/genes12122029.
10
Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.微小RNA在头颈部鳞状细胞癌转移和复发中的诊断及预后价值:一项系统评价与Meta分析
Front Oncol. 2021 Sep 27;11:711171. doi: 10.3389/fonc.2021.711171. eCollection 2021.
微小 RNA-199a-5p 通过抑制 EMT 相关转录因子 SOX4 抑制口腔鳞状细胞癌的迁移和侵袭。
Int J Mol Med. 2019 Jul;44(1):185-195. doi: 10.3892/ijmm.2019.4174. Epub 2019 Apr 25.
4
Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.血清 miR-626 和 miR-5100 是口腔鳞状细胞癌有前途的预后预测指标。
Theranostics. 2019 Jan 25;9(4):920-931. doi: 10.7150/thno.30339. eCollection 2019.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma.微小RNA-155-5p在口腔鳞状细胞癌中的潜在致癌作用及预后意义
Anticancer Res. 2018 Sep;38(9):5193-5200. doi: 10.21873/anticanres.12842.
7
MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.miR-200c 通过靶向 Akt 通路及其下游的 Glut1 抑制口腔鳞状细胞癌细胞的增殖。
Arch Oral Biol. 2018 Dec;96:52-57. doi: 10.1016/j.archoralbio.2018.06.003. Epub 2018 Jun 6.
8
MicroRNA-200c suppresses tumor metastasis in oral squamous carcinoma by inhibiting epithelial-mesenchymal transition.MicroRNA-200c 通过抑制上皮-间充质转化抑制口腔鳞状细胞癌的转移。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3415-3422. doi: 10.26355/eurrev_201806_15164.
9
Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.表达谱分析鉴定出一种新型的三信使核糖核酸特征,用于预测口腔鳞状细胞癌的总生存期。
Am J Cancer Res. 2018 Mar 1;8(3):450-461. eCollection 2018.
10
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.口腔鳞状细胞癌中miR-200家族微小RNA与上皮-间质转化标志物的失调
Oncol Lett. 2018 Jan;15(1):649-657. doi: 10.3892/ol.2017.7296. Epub 2017 Oct 31.